Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antibody-Dependent Cellular Phagocytosis (ADCP)
- Target
- ADCP
- Molecular classification
- Immunological Mechanism, Cellular Process
01
Overview
Antibody-dependent cellular phagocytosis (ADCP) is an immunological mechanism in which effector cells of the immune system, primarily professional phagocytes such as monocytes, macrophages, neutrophils, and eosinophils, recognize and engulf target cells or particles that have been opsonized (coated) with antibodies. This process is a critical component of the body's defense against pathogens and also plays a significant role in the therapeutic action of certain monoclonal antibodies used to treat cancer.
02
Mechanism of action
ADCP is a mechanism of action for monoclonal antibodies, where the antibody binds to a target on a cell (e.g., tumor cell), and the Fc region of the antibody is recognized by Fc receptors on effector cells (e.g., macrophages), leading to phagocytosis and destruction of the target cell.
03
Biological functions
Immune responsePathogen clearanceTumor cell eliminationEffector function of antibodies
04
Disease associations
InfectionCancerTherapeutic mechanism of action
05
Safety considerations
Potential for off-target effects of antibodiesEvasion mechanisms developed by pathogensTechnical challenges in ADCP assays
06
Interacting drugs
Rituximab
2 more in the full profile.
Beyond the preview
Go deeper on Antibody-Dependent Cellular Phagocytosis (ADCP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antibody-Dependent Cellular Phagocytosis (ADCP).